Amar Murugan Atara Biotherapeutics, Inc. (ATRA) insider trading activity

Amar Murugan is EVP, Chief Legal Officer of Atara Biotherapeutics, Inc.. Currently has a direct ownership of 26,827 shares of ATRA, which is worth approximately $352,506. The most recent transaction as insider was on Aug 16, 2024, when has been sold 1,158 shares (Common Stock) at a price of $6.63 per share, resulting in proceeds of $7,677. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 26.8K

0% 3M change

89.56% 12M change

Total Value Held $352,506

Amar Murugan Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 16 2024	SELL Open market or private sale	$7,677 $6.63 p/Share	1,158 Reduced 4.14%	26,827 Common Stock
May 16 2024	SELL Open market or private sale	$20,088 $0.62 p/Share	32,401 Reduced 4.45%	695,120 Common Stock
Mar 04 2024	SELL Open market or private sale	$7,231 $0.72 p/Share	10,044 Reduced 1.36%	727,521 Common Stock
Jan 08 2024	BUY Grant, award, or other acquisition	-	475,000 Added 39.17%	737,565 Common Stock
Nov 16 2023	SELL Open market or private sale	$3,239 $0.39 p/Share	8,307 Reduced 3.13%	257,084 Common Stock
Aug 16 2023	SELL Open market or private sale	$14,308 $1.65 p/Share	8,672 Reduced 3.16%	265,391 Common Stock
May 16 2023	SELL Open market or private sale	$17,113 $2.04 p/Share	8,389 Reduced 3.0%	270,945 Common Stock
Mar 02 2023	SELL Open market or private sale	$15,322 $3.63 p/Share	4,221 Reduced 1.49%	279,334 Common Stock
Mar 01 2023	BUY Grant, award, or other acquisition	-	155,375 Added 35.4%	283,555 Common Stock
Nov 16 2022	SELL Open market or private sale	$16,217 $4.49 p/Share	3,612 Reduced 2.75%	127,586 Common Stock
Aug 16 2022	SELL Open market or private sale	$17,287 $5.04 p/Share	3,430 Reduced 2.55%	131,198 Common Stock
May 17 2022	SELL Open market or private sale	$17,146 $5.32 p/Share	3,223 Reduced 2.35%	133,735 Common Stock
Mar 01 2022	SELL Open market or private sale	$25,409 $9.86 p/Share	2,577 Reduced 1.85%	136,958 Common Stock
Mar 01 2022	BUY Grant, award, or other acquisition	-	51,814 Added 27.08%	139,535 Common Stock
Nov 16 2021	SELL Open market or private sale	$36,363 $17.12 p/Share	2,124 Reduced 2.37%	87,540 Common Stock
Aug 17 2021	SELL Open market or private sale	$26,062 $12.53 p/Share	2,080 Reduced 2.27%	89,664 Common Stock
May 18 2021	SELL Open market or private sale	$82,659 $14.55 p/Share	5,681 Reduced 5.83%	91,744 Common Stock
Mar 01 2021	BUY Grant, award, or other acquisition	-	41,756 Added 30.0%	97,425 Common Stock

Also insider at

SLRN

ACELYRIN, Inc.

Chief Legal Officer

Amar Murugan

EVP, Chief Legal Officer

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATRA shares.

Notify only if

Value

Insider Trading

Get notified when an Atara Biotherapeutics, Inc. insider buys or sells ATRA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Atara Biotherapeutics, Inc.

Track Activities on ATRA

Account